Tag Archive for: commercial update

xeltis

Xeltis makes first commercial implant of aXess™, its vascular access device for hemodialysis

/in

Marks start of European commercial rollout of aXess™, bringing it into routine clinical practice Builds on CE mark approval in record time, underpinned by positive EU pivotal trial data Introduces a first-of-its-kind living vascular access solution for patients requiring hemodialysis EINDHOVEN, The Netherlands – 7 July, 2026 – Xeltis, a leading developer of transformative implants […]

Read more

Futura provides US regulatory and commercial update for MED3000

/in

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, is pleased to provide an update on good progress with its regulatory and commercial activities for MED3000. MED3000 is the Company’s breakthrough, topical gel formulation for treatment of erectile dysfunction (“ED”).  It has the potential […]

Read more
© Optimum Strategic Communications.